Publication

Transcriptional dysregulation in Huntington's disease

Related publications (113)

About
Privacy
Disclaimer

Graph Chatbot

Chat with Graph Search

Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.

DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.

Transcriptional dysregulation in Huntington's disease

Graph Chatbot

Chat with Graph Search

Impact of Mitofusin 2 in the Nucleus Accumbens on motivated behavior and underlying neurobiological mechanisms

Breakdown and rejuvenation of aging brain energy metabolism

Aging Fly Cell Atlas identifies exhaustive aging features at cellular resolution

Substrates and Cyclic Peptide Inhibitors of the Oligonucleotide-Activated Sirtuin 7

N-terminal mutant huntingtin deposition correlates with CAG repeat length and symptom onset, but not neuronal loss in Huntington's disease

Astrocyte-targeting RNA interference against mutated superoxide dismutase 1 induces motoneuron plasticity and protects fast-fatigable motor units in a mouse model of amyotrophic lateral sclerosis

An integrative approach to elucidate the mechanisms and dynamics of Huntingtin aggregation and inclusion formation in neuronal models of Huntington's Disease

Chromatin Proteomics to Study Epigenetics - Challenges and Opportunities

A New Chemoenzymatic Semisynthetic Approach Provides Insight into the Role of Phosphorylation beyond Exon1 of Huntingtin and Reveals N-Terminal Fragment Length-Dependent Distinct Mechanisms of Aggregation

Pharmacological characterization of mutant huntingtin aggregate-directed PET imaging tracer candidates